|
|
Article: Singapore Builds Base In Bulk Pharmaceuticals With Two New Projects
- Article from:
- Chemical Market Reporter
- Article date:
- May 19, 1997
- Author:
-
|
Copyright informationCOPYRIGHT 1997 Schnell Publishing Company, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
THE OPENING OF Schering-Plough Corporation's $200 million bulk pharmaceutical manufacturing plant and Rhone-Poulenc Rorer Inc.'s announcement of plans for a $50 million plant expansion to make active ingredients for its Lovenox/Clexane injectable heparin underscore Singapore's growing role in pharmaceutical raw materials.
The RPR expansion, due to go into production in 1999, will include new laboratories that will accommodate all operations of the facility, says David Manwaring, general manager and director of Rhone-Poulenc Rorer Manufacturing Pte., the company's Singapore subsidiary.
This includes sections for nedocromil sodium (an active ingredient of Filade ...
Related newspaper, magazine, and journal articles:
|
|
Article: White Horse to start producing tiles at new plant
New Straits Times;
May 12, 2001 ;
221 words
......White Horse to start producing tiles at new plant Edition: Main/Lifestyle; 2* Section...begin production at its RM113 million new plant in Johor's Tanjung Langsat Industrial...project has already been completed. The new plant will increase the factory's capacity...
|
|